BEND, OR , May 02, 2017 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB:SGBY) a biotech company with three subsidiaries; EVIO Labs, Signal Bay Services and Signal Bay Research, provides analytical testing, advisory and research services to the legal cannabis industry throughout the United States would like to take this opportunity to provide shareholders with an update on the Signal Bay Services division.

Signal Bay has recently completed application submissions for clients in Pennsylvania, Texas, and multiple jurisdictions in California.  The company has an excellent track record of clients successfully navigating the cannabis business application process and has helped clients attain multiple cultivation, processing and dispensary licenses in Nevada, Oregon, California and Maryland; and has advised clients in Massachusetts, Texas, Pennsylvania, and Hawaii. 

The application process in most states is a highly rigorous process that typically requires a business plan, extensive operating plans that cover topics ranging from employee training and security to environmental and community impacts, as well as demonstration of compliance with local ordinances.  The application responses ensure that the team is qualified to meet each state rules, which are put in place in part to meet the federal government’s standards for “strong and effective regulatory enforcement systems.”

Currently the company is accepting new clients to assist with medical marijuana applications in Ohio, Arkansas, and California. Cultivation applications are now being accepted in Ohio with large facility cultivation licenses due by June 16.  Arkansas will begin accepting cannabis business applications in July.  Several jurisdictions in California are currently, or will soon, open application windows.  

Lori Glauser, COO of Signal Bay Inc. and President of the company’s Services division stated, “With dozens of winning applications under our belt, Signal Bay has become a trusted advisor for clients who come back to us to apply in additional states.  Some of our clients now follow us from state to state – which creates a great long term relationship as they continue to retain us for both compliance consulting services, as well as analytical testing services.”  

Collectively, Signal Bay’s clients have developed cannabis cultivation, processing, retail, and wholesale businesses with deal flow in excess of $150 million invested to date.

About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based biotechnology company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides analytical testing services, research and management advisory services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities deploying our Cannabis Compliance Science accredited testing methodologies to ensure the safety and quality of the nation's cannabis supply. Learn more at or the company can be reached directly @ 1-888-544-EVIO.

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at or

Investor Relations: